PPI Library
(Non-Macrocyclic) |
11439 compounds
For cherry-picking
Update: 2020-07 |
ASINEX has been working on the design and synthesis of protein-protein interaction
(PPI) libraries since 2008. The file contains all available PPI (non-macrocyclic)
compounds selected from our Signature & BioDesign Libraries.
|
|
PPI Library
(Macrocyclic) |
3118 compounds
For cherry-picking
Update: 2020-07 |
The file contains all available PPI (macrocyclic) compounds selected from our
Signature & BioDesign Libraries.
|
|
SL#001
Mcl-1 Apoptosis |
80 compounds
Pre-Plated Set
Release: 2016 |
ASINEX has developed several acylsulfonamide derivatives with Mcl-1 binding potency
and improved physico-chemical characteristics.
|
|
SL#002
Bcl-xL Apoptosis
|
80 compounds
Pre-Plated Set
Release: 2016 |
ASINEX has identified dihydrobenzofurane as a functional a-helix mimetic displaying
uM Bcl-xL binding affinity determined by a fluorescence polarization
assay.
|
|
SL#011
MDM2-p53 (α-Helix mimetics)
|
80 compounds
Pre-Plated Set
Release: 2016 |
ASINEX has performed in-silico analyses of common structural futures of known MDM2
antagonists to build up a predictive pharmacophore model [1]. Several ɑ-helix
mimetic scaffolds were selected as p53 backbone mimetics and p53 binding epitope
mimetics [2,3]. The in vitro potency of compounds was confirmed in a fluorescence
polarization assay, with the IC50s ranging from 1 to 10 µM.
|
|
SL#025
BH3 mimetics
|
80 compounds
Pre-Plated Set
Release: 2016 |
Extensive in-vitro screening of ASINEX’s natural product-like compound and α-helix
mimetic collections against Bcl-2 family proteins has resulted in a series of
polycyclic acids showing µM inhibitory activity of Bcl-xL. In silico simulations
suggest a possible binding mode mimicking hot spot interactions of the native
pro-apoptotic BAK peptide by projecting hydrophobic substituents such as Leu578,
Ile581 and Ile585 of Bak.
|
|
SL#032
Macrocyclic BH3 mimetics |
80 compounds
Pre-Plated Set
Release: 2016 |
Extensive in vitro screening of the Asinex Macrocyclic collection has revealed a
series of molecules showing a μM range of activity against anti-apototic proteins
Bcl-2 and Mcl-1. In silico modeling studies suggest that some active macrocycles can
adopt a-helix-mimetic conformations that effectively mimic the BH3-epitope of
pro-apoptotic peptides (e.g. Bak, Bax). |
|
SL#033
PD1/PD-L1 inhibitors
|
80 compounds
Pre-Plated Set
Release: 2016 |
By utilizing a combination of scaffold hopping and structure-based design strategies
ASINEX has developed a library of small molecules for IDO1 drug discovery. Selected
compounds have shown significant IDO1 inhibitory activity in vitro as measured in
the enzymatic biochemical assays.
|
|
SL#034
Macrocyclic β-turn mimetics |
80 compounds
Pre-Plated Set
Release: 2016 |
Asinex has created a library of partially peptidic macrocyclic beta-turn mimetics
that are able to reproduce the orientation of key amino-acid side chains forming a
b-turn-like motif.
|
|
SL#054
Menin-MLL inhibitors (PPI)
|
80 compounds
Pre-Plated Set
Release: 2016 |
2D similarity search through ASINEX’s compound collection has resulted in several
thienopyrimidine-based analogs, close analogs of MI-503. Such analogs could be
interesting chemical probes for MLL-directed research.
|
|
